USPTO serial 75407884
MERISTEM
Reviewed by CopyMark Law Group
Reg. 2403115Status 710
- Filing date
- Status date
- Registration date
- Nov 14, 2000
- Examiner
- JACKSON, WILLIAM D
- Law office
- —
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with MERISTEM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
63170 Aubiere, FR
63170 Aubiere, FR
63100 CLEMONT-FERRAND, FR
63170 Aubiere, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John A. Clifford
John A. Clifford Merchant & Gould P.C.P.O. Box 2910MINNEAPOLIS, MN 55402-0910UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Chemicals for use in the manufacture of photographic materials, namely, dyes, wetting agents, fixing agents, developing agents, and stabilizers; chemicals for use in the manufacture of paints, dyes, cosmetics, glues and surfactants; chemicals for use in the manufacture of horticultural materials, namely, soil conditioners, fertilizers; chemicals for use in the manufacture of hormones, peptides, enzymes, and proteins, namely, plant and animal and microbial growth hormones, growth regulators and inhibitors, diagnostic reagents, cell growth media, cell regulatory agents, amino acids, DNA fragments, RNA fragments, DNA probes, RNA probes, genetic cloning materials, genetic expression amplifiers ] | SECTION 8 - CANCELLED | — |
| 003 | [ Proteins for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, collagen, serum albumin, RNA, DNA and their extracts, amino acids, ribosomes, ceramides, immunostimulating or immunoregulatory hormones, all obtained from plants; and enzymes for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, proteases, hydrolases, lipases, deshydroxylases and cellulases, all obtained from plants ] | SECTION 8 - CANCELLED | — |
| 005 | [ pharmaceutical preparations for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely, human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; veterinary preparations for the treatment of rabies, obesity, auto-immune diseases, namely, feline immunodeficiency virus and simian immunodeficiency virus, in livestock, domestic pets and wild animals, namely, foxes and rodents; acaricides, algaccides, biopesticides, herbicides, insecticides, miticides, pesticides and weed killers for agricultural, domestic or commercial use; pharmaceutical preparations produced from plants or containing proteins produced from plants, for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely, human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; therapeutic proteins, hormones, peptides and their complexes, derivatives and cofactors, namely, human serum albumin, lactoferrin, hemoglobin, collagen and procollagen for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely, immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; vaccines including antibodies or glycoproteins, namely, glycoprotein G, lipases, namely, gastric lipase, pancreatic lipase; and medicines and pharmaceutical preparations obtained from genetically modified plants or containing the extracts of genetically modified plants for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely, immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies ] | SECTION 8 - CANCELLED | — |
| 042 | Scientific and industrial research, namely biotechnological research on chemical products intended for industry, science, photography, agriculture, horticulture and forestry, on proteins for pharmaceutical use or for cosmetic use, these proteins being produced from plants, on pharmaceutical and veterinary products and hygiene products coming under the pharmaceutical monopoly, on biotechnological products produced from plants; biological and biotechnological laboratory services; research and development work in plant-based biotechnology | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Biocem S.A.
- Other trademarks owned by Biocem S.A.
- Other trademarks owned by MERISTEM THERAPEUTICS
- Other trademarks owned by Biocem S.A.
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named MERISTEM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 17, 2011 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Feb 1, 2008 | 8.PR | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED | — |
| Dec 17, 2007 | PRA8 | RESPONSE RECEIVED TO POST REG. ACTION - SEC. 8 | — |
| Dec 17, 2007 | PAPER RECEIVED | — | |
| Nov 7, 2007 | PRA8 | POST REGISTRATION ACTION MAILED - SEC. 8 | — |
| Jul 26, 2007 | PRA8 | RESPONSE RECEIVED TO POST REG. ACTION - SEC. 8 | — |
| Jul 26, 2007 | PAPER RECEIVED | — | |
| Jun 14, 2007 | PRA8 | POST REGISTRATION ACTION MAILED - SEC. 8 | — |
| Jun 7, 2007 | PLGL | ASSIGNED TO PARALEGAL | — |
| May 14, 2007 | 8.AF | REGISTERED - SEC. 8 (6-YR) FILED | — |
| May 14, 2007 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Aug 10, 2006 | CFIT | CASE FILE IN TICRS | — |
| Nov 14, 2000 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 1, 2000 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Mar 28, 2000 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 25, 2000 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 12, 1999 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 7, 1999 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 25, 1999 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 26, 1999 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Jan 14, 1999 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 31, 1998 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 27, 1998 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 18, 1998 | DOCK | ASSIGNED TO EXAMINER | — |